Pain Relief Investigation of NeuroModulation Therapy in Adult Humans

NCT00253032 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2006-03-03

No results posted yet for this study

Summary

The study is being performed to determine the efficacy and safety of Fralex Neuromodulation Therapy (F-NMT), delivered by the Fralex PRIMA device, in reducing chronic musculoskeletal pain.

Conditions

  • Chronic Musculoskeletal Pain

Interventions

DEVICE

PRIMA

Sponsors & Collaborators

  • PharmaNet

    collaborator INDUSTRY
  • Fralex Therapeutics

    lead INDUSTRY

Eligibility

Sex
Healthy Volunteers
No

Timeline & Regulatory

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00253032 on ClinicalTrials.gov